Skip to main content
Equibles

HARBOUR INVESTMENTS, INC.

Position in CLLS — Cellectis S.A.

CIK 810121 MADISON, WI
Back to CLLS Full portfolio

Position in CLLS

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$13,500
-$765 QoQ
Shares Held
4,500
0.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#14
of 27 holders
Holding Since
Mar 2021
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CLLS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

HARBOUR INVESTMENTS, INC. holds $3,690,646 across 135 Biotechnology names. CLLS ranks #33 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VKTX
Viking Therapeutics, Inc.
 16,451 $641,753
2 REGN
Regeneron Pharmaceuticals, Inc.
 636 $396,571
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 734 $364,599
4 JAZZ
Jazz Pharmaceuticals plc
 1,365 $328,924
5 OMER
Omeros Corp
 23,139 $220,051
6 CRSP
CRISPR Therapeutics AG
 3,533 $192,689
7 STOK
Stoke Therapeutics, Inc.
 4,413 $144,393
8 NTLA
Intellia Therapeutics, Inc.
 7,534 $127,475

All Filings in CLLS

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $13,500 4,500
2026-03-31 $14,265 4,500
2025-12-31 $21,780 4,500
2025-09-30 $12,825 4,500
2025-06-30 $6,862 4,500
2025-03-31 $5,580 4,500
2024-12-31 $8,100 4,500
2024-09-30 $12,932 6,100
2024-06-30 $11,407 6,100
2024-03-31 $16,165 6,100
2021-09-30 $20,756 1,646
2021-06-30 $19,600 1,267
2021-03-31 $41,390 2,048